|
|
US 7,544,678 B2 |
|
| Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) |
| Andrew Robert Marks, Larchmont, N.Y. (US); Donald W. Landry, New York, N.Y. (US); Shixian Deng, White Plains, N.Y. (US); and Zhen Zhuang Cheng, Elmhurst, N.Y. (US) |
| Assigned to The Trustees of Columbia University In the City of New York, New York, N.Y. (US) |
| Filed on Mar. 23, 2005, as Appl. No. 11/88,058. |
| Application 11/088058 is a continuation of application No. 10/763498, filed on Jan. 22, 2004, abandoned. |
| Prior Publication US 2005/0187386 A1, Aug. 25, 2005 |
| Int. Cl. A61P 9/00 (2006.01); A61K 31/553 (2006.01); A61K 31/554 (2006.01); A61K 31/675 (2006.01); C07F 9/553 (2006.01); C07D 281/02 (2006.01)
|
